In a highly competitive and multi-billion dollar weight loss drug market, Eli Lilly’s innovative strategy focuses on direct-to-consumer initiatives. On January 4th, 2023, Eli Lilly unveiled LillyDirect, a direct-to-consumer website tailored to connect U.S. patients grappling with migraine, diabetes, or obesity with telehealth providers. This platform facilitates the delivery of select Lilly medications directly to